Share-based Payment Arrangement, Expense of Inhibrx Biosciences, Inc. for 30 May 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Inhibrx Biosciences, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate for 30 May 2024.
  • Inhibrx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 May 2024 was $1,800,000.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)

Inhibrx Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,800,000 30 May 2024 10-K 17 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.